Cardiovascular Drugs and Therapyis dedicated to the development of cardiovascular drug, device, and cell therapy from bench to bedside. The journals takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents,Cardiova...
心血管药物和治疗(Cardiovascular Drugs And Therapy)是一本由Springer US出版的一本医学-心血管系统学术刊物,主要报道医学-心血管系统相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1987年,出版周期Bimonthly。2021-2022年最新版WOS分区等级:Q2,2023年发布的影响因子为3.1,CiteScore指数8.3,SJR指数0.973。本刊...
《Cardiovascular Drugs And Therapy》(《心血管药物和治疗》)是一本由Springer US出版的医学-心血管系统学术刊物,主要刊载医学-心血管系统相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于1987年,出版周期Bimonthly。2023年发布的影响因子为3.1...
收稿方向:Cardiovascular Drugs And Therapy聚焦于新治疗剂方面最令人振奋的工作,关注高脂血症、糖尿病和其他心脏代谢疾病、动脉粥样硬化、缺血综合症、心力衰竭、心肌病、瓣膜性心脏病和心律失常的治疗发展。其中包括作用机制和信号通路,它们对新药开发的潜力,老药的新适应症,治疗的遗传方法,以及设备和细胞治疗的新方向,...
CARDIOVASCULAR DRUGS AND THERAPY官网显示最新影响因子为3.947分,影响因子近两年相对稳定,目前被34个国际数据库收录和摘要中。 02 费用 根据CARDIOVASCULAR DRUGS AND THERAPY官网显示: 1.传统的出版模式--已发表的文章可供订阅或付费阅读特定文章的机构和个人使用。 2.开放获取--当文章被接受发表时,作者或资助者支付文...
期刊Cardiovascular Drugs and Therapy,最新影响因子为3.4,近年发展较稳定。 后台扫描,可以查看更多期刊信息 审稿周期 从Cardiovascular Drugs and Therapy官网数据显示来看,平均6天给出第一个决定,平均3-4个月左右可接收,审稿速度有快有慢。 版面费 期刊Cardiovascular Drugs and Therapy为开放期刊。传统模式,不收版面费...
期刊邮箱: 投稿网址:https://www.editorialmanager.com/cdty/ 期刊网址:https://www.springer.com/journal/10557 出版商网址:http://www.springeronline.comCardiovascular Drugs and Therapy《心血管药物与治疗》(官网投稿)的期刊点评返回该期刊 本刊点评浏览 暂无点评信息 我要点评 欢迎点评!让信息更透明,使...
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol 2011; 8: 13-28.Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Car- diol 2011; 8: 13-28...
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring the most necessary information in a timely and concise format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field...
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic ...